Treatment Resistant Mental Health Therapies Max Contact Hours Awarded
: 6.0Max Pharmacotherapeutic Hours Awarded
Psychedelics are a class of drugs whose primary action is to trigger experiences via other serotonin receptor agonism, causing thought and visual/auditory changes. Major psychedelic drugs include mescaline, LSD, psilocybin, marijuana, MDMA and DMT. Studies conducted in a psychotherapeutic setting reveal that these drugs may assist with addressing treatment-resistant depression, alcoholism and nicotine addiction. Discussions will include legal issues, off-label use of unconventional medications, and non-pharmaceutical therapies in the treatment of specific mental health conditions.
May 8, 2020
8:00 am – 3:15 pm
Location: Acute Care Education , Vancouver, WA
Who Should Attend?
NP’s and RN’s who care for clients with mental health conditions.
- Intranasal Ketamine
- Laws & Regulations Regarding Psychedelic Medications
- Off-Label Use of Medications in the Treatment of Depression & PTSD
- Devices and Non-medication Treatments in the Treatment of Depression, Anxiety & Insomnia
- Legal Issues and Proper Documentation of Off Label Use of Medications
Speaker: Brooks Oglesby-Junk, BSN, MSN, RN, APRN, PMHNP, ANP
EMPLOYERS: You may register up to 6 staff at one time by using this link.
Registration includes: Attendance at program, downloadable program handouts, coffee, tea, water, continental breakfast, and snacks. Wi-fi is available in the conference center.
Terms & Conditions and Cancellation Policy
Need Registration Help? Learn how to create a profile and register for a program .